Mortality News and Research

RSS

Sorrento receives NIAID Phase I STTR grant to develop vaccines against C. difficile infection

Sorrento Therapeutics, Inc. announced today that it has received a Phase I Small Business Technology Transfer Research grant from the National Institute of Allergy and Infectious Diseases of the National Institutes of Health.

29 Jul 2011

Breast cancer survival and lymph nodes

A large new study has found that a lymph node-sparing test hailed as revolutionary for its conservative approach does not lead to longer survival times for women undergoing lumpectomies whose early-stage breast cancer has spread microscopically.

27 Jul 2011

Researchers compile first global estimates of coeliac disease and associated mortality

Researchers from Umeå University, Sweden and University of the Witwatersrand, South Africa, have compiled the first global estimates of coeliac disease and associated mortality, just published in the journal PLoS ONE.

27 Jul 2011

Study reveals clear need to halt escalating use of Caesarean sections

Caesarean section rates are steadily increasing globally. Requiring two doctors to agree that a Caesarean section is the best way to deliver a baby, rather than just needing one opinion, providing internal feedback to doctors on the number of operations performed and seeking support from local opinion leaders may reduce the use of this procedure.

27 Jul 2011

Follow-up dose recommended to defend children against pandemic virus outbreaks

Researchers from Australia determined that pediatric liver transplant patients who received a single-dose of the H1N1 vaccine were not adequately protected against the virus compared to healthy children.

27 Jul 2011

Gates Foundation awards phase 1 grant to St. Joseph's scientist for post-partum research

The Bill and Melinda Gates Foundation has awarded Robert Garfield, PhD, a researcher at St. Joseph's Hospital and Medical Center in Phoenix, a $100,000 phase 1 grant to develop a device to prevent post-partum hemorrhage.

27 Jul 2011

Four-year study to test effectiveness of WHO Safe Childbirth program

Harvard School of Public Health (HSPH) has been awarded a $14.1 million, four-year grant from the Bill & Melinda Gates Foundation to test the effectiveness of an innovative checklist-based childbirth safety program in reducing deaths and improving outcomes of mothers and infants in 120 hospitals in India.

27 Jul 2011

Health Canada issues notice of compliance for OCPI's SAMSCA to treat hyponatremia

Otsuka Canada Pharmaceutical Inc. (OCPI) announced today that Health Canada has issued a notice of compliance for SAMSCA (tolvaptan), the first medicine approved in Canada for the treatment of hyponatremia.

27 Jul 2011

Racal differences in breast cancer survival: Study

Black women are more likely to die from breast cancer than white women with obesity considered a significant factor. But a new study shows that that the cause of the difference does not lie in obesity alone. As a group, black women in the U.S. tend to be heavier than whites and researchers had thought that might explain why only 78 percent survive five years after diagnosis, compared to 90 percent of white women.

26 Jul 2011

Hormone therapy may be hazardous in men with pre-existing heart conditions

Adding hormone therapy to radiation therapy has been proven in randomized clinical trials to improve overall survival for men with intermediate- and high-risk prostate cancer. However, adding hormone therapy may reduce overall survival in men with pre-existing heart conditions, even if they have high-risk prostate cancer according to a new study just published online in advance of print in the International Journal of Radiation Oncology·Biology·Physics, the official scientific journal of ASTRO.

26 Jul 2011

Majority of parents unaware of medical research participation opportunities for children

One in nine adults have participated in medical research. In contrast, only one in 20 children have done so. Those are the findings of a poll earlier this year by the University of Michigan C.S. Mott Children's Hospital National Poll on Children's Health. The poll asked adults and parents about their views on medical research and past participation for themselves and their children.

26 Jul 2011

Erionite in North Dakota roads may increase risk of mesothelioma

As school buses drive down the gravel roads in Dunn County, North Dakota, they stir up more than dirt. The clouds of dust left in their wake contain such high levels of the mineral erionite that those who breathe in the air every day are at an increased risk of developing mesothelioma, a type of cancer of the membranes around the lungs, new research shows.

26 Jul 2011

C-sections on the rise: One in three mothers opting for procedure

According to the latest study reports, one in three births in the U.S. are now delivered by Caesarean section, which is an all time high and an increasd of 25 percent over seven years.

24 Jul 2011

Research roundup: Restricting Medigap coverage; Hospital-acquired infections

Increases In Mortality, Length Of Stay, And Cost Associated With Hospital-Acquired Infections In Trauma Patients -- This study explores the clinical and economic burden of hospital-acquired infections, the most common complication in hospitalized patients, for trauma patients.

22 Jul 2011

Anesthesia-associated mortality rises again

In pure numerical terms, anesthesia-associated mortality has risen again. The reasons for this are the disproportionate increase in the numbers of older and multimorbid patients and surgical procedures that would have been unthinkable in the past.

22 Jul 2011

22nd Century receives FDA approval for X-22 IND to conduct Phase II-B smoking cessation trial

22nd Century Group, Inc., a company focused on smoking cessation and tobacco harm reduction products, today announced that the U.S. Food & Drug Administration (FDA) has cleared an Investigational New Drug (IND) Application to conduct a Phase II-B clinical trial using X-22, a prescription smoking cessation aid in development.

22 Jul 2011

Taiho announces results of TAS-102 Phase II trial for metastatic colorectal cancer

Taiho Pharmaceutical Co., Ltd. announced on July 22 the results of a randomized, Phase II clinical trial for the novel oral nucleoside antitumor agent TAS-102 under development by the company for metastatic colorectal cancer, at the 9th Annual Meeting of the Japanese Society of Medical Oncology held in Yokohama.

22 Jul 2011

HIV-infected MSM more likely to contract HCV through sex

Sexual transmission of hepatitis C virus (HCV) is considered rare. But a new study by researchers at Mount Sinai School of Medicine, working with the Centers for Disease Control and Prevention (CDC), provides substantial evidence that men with HIV who have sex with other men (MSM) are at increased risk for contracting HCV through sex.

22 Jul 2011

Optimism could protect you from stroke: Study

The latest research from the University of Michigan shows that optimism reduces the risk of stroke. In a study of 6,044 adults over 50 with no history of stroke, optimism was associated with significantly reduced risk of stroke, even when controlling for stroke risk factors such as high blood pressure, heart disease and body mass index.

21 Jul 2011

Researchers at Macquarie trial new program to help improve neglected area of aged care

In a world first, researchers at the Centre for Emotional Health, Macquarie University are developing psychological treatments, which simultaneously target both anxiety and depression in older adults. Despite the fact that symptoms of anxiety and depression are typically suffered together, no program currently exists which is aimed at helping older adults tackle both disorders at once.

21 Jul 2011

Mortality News and Research

Sorrento receives NIAID Phase I STTR grant to develop vaccines against C. difficile infection

Breast cancer survival and lymph nodes

Researchers compile first global estimates of coeliac disease and associated mortality

Study reveals clear need to halt escalating use of Caesarean sections

Follow-up dose recommended to defend children against pandemic virus outbreaks

Gates Foundation awards phase 1 grant to St. Joseph's scientist for post-partum research

Four-year study to test effectiveness of WHO Safe Childbirth program

Health Canada issues notice of compliance for OCPI's SAMSCA to treat hyponatremia

Racal differences in breast cancer survival: Study

Hormone therapy may be hazardous in men with pre-existing heart conditions

Majority of parents unaware of medical research participation opportunities for children

Erionite in North Dakota roads may increase risk of mesothelioma

C-sections on the rise: One in three mothers opting for procedure

Research roundup: Restricting Medigap coverage; Hospital-acquired infections

Anesthesia-associated mortality rises again

22nd Century receives FDA approval for X-22 IND to conduct Phase II-B smoking cessation trial

Taiho announces results of TAS-102 Phase II trial for metastatic colorectal cancer

HIV-infected MSM more likely to contract HCV through sex

Optimism could protect you from stroke: Study

Researchers at Macquarie trial new program to help improve neglected area of aged care

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News